Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$4.46
Last update: Dec 15, 1:19 PM
Comments
Loading...
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Inventiva (IVA) stock?
You can purchase shares of Inventiva (NASDAQ:IVA) through any online brokerage.
Who are Inventiva (IVA) competitors?
Other companies in Inventiva’s space includes: KalVista Pharmaceuticals Inc (NASDAQ:KALV), Gyre Therapeutics Inc (NASDAQ:GYRE), Valneva SE (NASDAQ:VALN), Replimune Group Inc (NASDAQ:REPL) and Day One Biopharmaceuticals Inc (NASDAQ:DAWN).
What is the forecast, or price target, for Inventiva (IVA) stock?
Inventiva has a consensus price target of $15.10.
What is the current price for Inventiva (IVA)?
The stock price for Inventiva (NASDAQ: IVA) is $4.46 last updated December 15, 2025 at 1:19 PM EST.
Does Inventiva (IVA) pay a dividend?
There are no upcoming dividends for Inventiva.
When is Inventiva (NASDAQ:IVA) reporting earnings?
Inventiva does not have any upcoming earnings scheduled.
Is Inventiva (IVA) going to split?
There is no upcoming split for Inventiva.
What sector and industry does Inventiva (IVA) operate in?
Inventiva is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
